The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent
responsible for the coronavirus disease 2019 (COVID-19). The high rate of mutation of this …

Abstract The SARS-CoV-2 Delta variant has evolved as the dominant strain of the current
pandemic. Studies have shown that this variant has increased infectivity/viral load, and …

The rapid and presumptive detection of SARS-CoV-2 variants may be performed using
multiplex RT-PCR assays. The aim of this study was to evaluate the diagnostic performance …

Since the end of 2019, the world has been challenged by the coronavirus disease 2019
(COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kappa (B. 1.617. 1)
variant represented the main variant of concern (VOC) for the epidemic in India in May 2021 …

Coronavirus disease 2019 (COVID-19), the global pandemic caused by severe acute
respiratory syndrome 2 virus (SARS-CoV-2) infection, has caused millions of infections and …

Given the significant decline in vaccine efficacy against Omicron, the development of novel
vaccines with specific or broad-spectrum effectiveness is paramount. In this study, we …

With the emergence of more variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and the immune evasion of these variants from existing vaccines, the …

Objectives Considering the spread of new genetic variants and their impact on public health,
it is important to have assays that are able to rapidly detect SARS-CoV-2 variants. Methods …

The rapid and presumptive detection of SARS-CoV-2 variants may be performed using
multiplex RT-PCR assays. The aim of this study was to evaluate the diagnostic performance …